Ozempic and Wegovy are the two brand names that Novo Nordisk uses to market injectable Semaglutide. Ozempic is used to treat type 2 diabetes and prevent major cardiovascular problems in certain patients, while Wegovy is used for chronic weight management and helps with weight loss.
If you are struggling with being overweight or have weight-related medical conditions such as type 2 diabetes, high blood pressure, or high cholesterol, Semaglutide may help you. When used with diet and exercise Semaglutide offers many benefits including:
In a randomized clinical trial of adults with overweight or obesity, 1961 participants completed a 20-week run-in of weekly treatment with subcutaneous semaglutide, 2.4 mg, with a mean weight loss of 10.6% After 68 weeks the total was 14.9% weight loss.
New England Journal of Medicine:
While patients will notice some significant body weight loss in the first month, the full benefits are usually fully noticed after three to six months of treatment. The medication dose must be increased gradually over 16 to 20 weeks. To better tolerate the medication, it will be increased over a 16-week period.
Common side effects may include:
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
*results may vary based on the treatment plan.
Dosage Protocol: Once a week shot
Office Visit: $125
Semaglutide Price: Depends on Dosage